menu
    • menu
    [{"orgOrder":0,"company":"Veraxa Biotech","sponsor":"Voyager Acquisition Corp","pharmaFlowCategory":"D","therapeuticArea":"Oncology","country":"GERMANY","productType":"Antibody-drug Conjugate","year":"2025","type":"Merger","leadProduct":"VX-A902","moa":"HER2","graph1":"Oncology","graph2":"Discovery","graph3":"Veraxa Biotech","amount2":0,"highestDevelopmentShortName":"Discovery","therapeuticAreaShortName":"Oncology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Veraxa Biotech \/ Voyager Acquisition Corp","highestDevelopmentStatusID":"2","companyTruncated":"Veraxa Biotech \/ Voyager Acquisition Corp"}]

    Find Clinical Drug Pipeline Developments & Deals by Veraxa Biotech

    Menu

    Veraxa Biotech

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            Veraxa Biotech

                            Germany arrow
                            Vietnam Medi Pharm
                            Not Confirmed

                            Veraxa Biotech

                            Germany arrow
                            Vietnam Medi Pharm
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : VX-A902

                            Therapeutic Area : Oncology

                            Study Phase : Discovery

                            Sponsor : Voyager Acquisition Corp

                            Deal Size : Undisclosed

                            Deal Type : Merger

                            DEALS_DEV arrow-down

                            Veraxa and Voyager Merge to Form Nasdaq Biotech for Cancer Pipeline

                            Details : The combined company will focus on the development of a comprehensive pipeline of next-generation cancer therapies, including novel ADC, VX-A902, and Bispecific TCE candidates.

                            Product Name : VX-A902

                            Product Type : Antibody-drug Conjugate

                            Upfront Cash : Undisclosed

                            April 23, 2025

                            Lead Product(s) : VX-A902

                            Therapeutic Area : Oncology

                            Highest Development Status : Discovery

                            Sponsor : Voyager Acquisition Corp

                            Deal Size : Undisclosed

                            Deal Type : Merger

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth